Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BIO-TECHNE (TECH) Net Margin: 2009-2025

Historic Net Margin for BIO-TECHNE (TECH) over the last 16 years, with Sep 2025 value amounting to 13.33%.

  • BIO-TECHNE's Net Margin rose 172.00% to 13.33% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.21%, marking a year-over-year decrease of 723.00%. This contributed to the annual value of 1.82% for FY2025, which is 921.00% down from last year.
  • Latest data reveals that BIO-TECHNE reported Net Margin of 13.33% as of Q3 2025, which was up 161.36% from -21.72% recorded in Q2 2025.
  • BIO-TECHNE's 5-year Net Margin high stood at 4,486.70% for Q3 2022, and its period low was -21.72% during Q2 2025.
  • In the last 3 years, BIO-TECHNE's Net Margin had a median value of 11.75% in 2024 and averaged 9.63%.
  • In the last 5 years, BIO-TECHNE's Net Margin surged by 445,993bps in 2022 and then crashed by 446,829bps in 2023.
  • BIO-TECHNE's Net Margin (Quarterly) stood at 26.76% in 2021, then slumped by 835bps to 18.41% in 2022, then slumped by 834bps to 10.08% in 2023, then skyrocketed by 167bps to 11.75% in 2024, then surged by 172bps to 13.33% in 2025.
  • Its Net Margin was 13.33% in Q3 2025, compared to -21.72% in Q2 2025 and 7.14% in Q1 2025.